Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

PURPOSE: To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer. PATIENTS AND METHODS: Breast International Group (BIG) trial 1-98 randomly assigned 8,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Viale, Giuseppe, Giobbie-Hurder, Anita, Regan, Meredith M., Coates, Alan S., Mastropasqua, Mauro G., Dell'Orto, Patrizia, Maiorano, Eugenio, MacGrogan, Gaëtan, Braye, Stephen G., Öhlschlegel, Christian, Neven, Patrick, Orosz, Zsolt, Olszewski, Wojciech P., Knox, Fiona, Thürlimann, Beat, Price, Karen N., Castiglione-Gertsch, Monica, Gelber, Richard D., Gusterson, Barry A., Goldhirsch, Aron
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2008
Témata:
Breast Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651094/
https://ncbi.nlm.nih.gov/pubmed/18981464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.0829
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky